SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-012969
Filing Date
2020-11-06
Accepted
2020-11-05 18:44:15
Documents
62
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xncr-20200930x10q.htm   iXBRL 10-Q 2120726
2 EX-10.1 xncr-20200930xex10d1.htm EX-10.1 15212
3 EX-10.2 xncr-20200930xex10d2.htm EX-10.2 20665
4 EX-31.1 xncr-20200930xex31d1.htm EX-31.1 17316
5 EX-31.2 xncr-20200930xex31d2.htm EX-31.2 17301
6 EX-32.1 xncr-20200930xex32d1.htm EX-32.1 9332
  Complete submission text file 0001558370-20-012969.txt   8580550

Data Files

Seq Description Document Type Size
7 EX-101.SCH xncr-20200930.xsd EX-101.SCH 45178
8 EX-101.CAL xncr-20200930_cal.xml EX-101.CAL 55797
9 EX-101.DEF xncr-20200930_def.xml EX-101.DEF 177508
10 EX-101.LAB xncr-20200930_lab.xml EX-101.LAB 472997
11 EX-101.PRE xncr-20200930_pre.xml EX-101.PRE 341460
12 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20200930x10q_htm.xml XML 1766439
Mailing Address 111 WEST LEMON AVE MONROVIA CA 91016
Business Address 111 WEST LEMON AVE MONROVIA CA 91016 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36182 | Film No.: 201291966
SIC: 2834 Pharmaceutical Preparations